IRadimed Corporation

NASDAQ: IRMD · Real-Time Price · USD
70.32
0.17 (0.24%)
At close: Aug 15, 2025, 9:55 AM

IRadimed Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
19.23M 17.19M 12.83M 9.33M
Depreciation & Amortization
817.66K 765.18K 670.67K 1.41M
Stock-Based Compensation
2.52M 2.19M 1.39M 1.46M
Other Working Capital
-277.58K -6.54M 3.37M -637.72K
Other Non-Cash Items
-3.02K 402.32K 148.74K 119.04K
Deferred Income Tax
-697.65K -1.17M 57.1K 523.61K
Change in Working Capital
3.75M -5.91M -5.06M -1.58M
Operating Cash Flow
25.62M 13.47M 10.04M 11.26M
Capital Expenditures
-8.01M -8.01M -1.87M -741.76K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a 500K 1.39M
Other Investing Acitivies
-811.75K -566.66K -551.98K 1.13M
Investing Cash Flow
-8.82M -8.01M -1.37M 648.24K
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a -610.35K -293.98K -598.82K
Dividend Paid
-13.68M -13.22M -12.56M n/a
Other Financial Acitivies
-688.16K -433.6K -147.27K 24.43K
Financial Cash Flow
-14.34M -13.66M -12.71M 24.43K
Net Cash Flow
2.47M -8.2M -4.04M 11.93M
Free Cash Flow
17.62M 5.46M 8.17M 10.52M